This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Johann Bergholz: Innovator in Cancer Treatment
Introduction: Johann Bergholz is a prominent inventor based in Cambridge, MA, known for his significant contributions to cancer treatment research. He has developed innovative methods aimed at addressing critical challenges in the medical field, particularly concerning PTEN deficient epithelial cancers.
Latest Patents: Bergholz holds a patent for "Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents." This invention focuses on novel approaches to enhance treatment efficacy for patients suffering from these specific types of cancers.
Career Highlights: Bergholz is affiliated with the Dana-Farber Cancer Institute Inc., where he has dedicated his career to advancing cancer research. His work has been instrumental in developing targeted therapies that improve patient outcomes.
Collaborations: He has collaborated with notable colleagues in the field, including Jean Zhao and Gordon James Freeman, contributing to a rich environment of innovation and research.
Conclusion: Johann Bergholz exemplifies the spirit of innovation in the medical field, with his groundbreaking patent and commitment to improving cancer treatment. His work continues to inspire advancements in oncology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile